Showing results (411-420 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|December 29, 2022
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database AnalysisSameh H Emile, Nir Horesh, Michael R Freund, et al.
JAMA Oncology|December 29, 2022
Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021Sundeep Agrawal, Shaily Arora, Laleh Amiri-Kordestani, et al.
JAMA Oncology|June 23, 2022
Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and EthnicityMarissa B Lawson, Michael C S Bissell, Diana L Miglioretti, et al.
JAMA Oncology|June 23, 2022
Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical TrialAlexander Stein, Lisa Paschold, Joseph Tintelnot, et al.
JAMA Oncology|December 1, 2022
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical TrialNancy U Lin, Rashmi K Murthy, Vandana Abramson, et al.
JAMA Oncology|June 9, 2022
Evaluation of the Molecular Landscape of Pediatric Thyroid Nodules and Use of a Multigene Genomic Classifier in ChildrenJean-Nicolas Gallant, Sheau-Chiann Chen, Carlos A Ortega, et al.
JAMA Oncology|May 5, 2022
Evaluation of Safety of Treatment With Anti-Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid Tumors: A Phase 1 Nonrandomized Clinical TrialMiao-Zhen Qiu, Yang Zhang, Ye Guo, et al.
JAMA Oncology|May 5, 2022
Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US WomenWenjie Ma, Molin Wang, Kai Wang, et al.
JAMA Oncology|October 14, 2021
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical TrialCaicun Zhou, Suresh S Ramalingam, Tae Min Kim, et al.
JAMA Oncology|April 7, 2022
Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast CancerCatalina Malinowski, Xiudong Lei, Hui Zhao, et al.
Pageof 161